New therapeutic principles in dyslipidaemia: Focus on LDL and Lp(a) lowering drugs
Dyslipidaemias play a key role in determining cardiovascular risk; the discovery of statins has contributed a very effective approach. However, many patients do not achieve, at the maximal tolerated dose, the recommended goals for low-density lipoprotein-cholesterol (LDL-C), non-high-density lipopro...
| Main Authors: | , , |
|---|---|
| Format: | Journal Article |
| Published: |
Oxford University Press
2013
|
| Online Access: | http://hdl.handle.net/20.500.11937/55365 |